Kevin D Freeman
Director at Galectin Therapeutics Inc (GALT)
Purchase track record
Below average. Based on 3 purchases with a full 90 days of price history.
12
Avg. 90-day return-28.3%
vs. S&P 500-23.8%
Beat the market0%
Paper profit on buys+$6K
Total bought / sold$59K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Dec 23SEC | GALTGalectin Therapeutics Inc | Buy | 5,50055,269 held (+11%) | $3.55 | $20K | +11.0% |
| Dec 23SEC | GALTGalectin Therapeutics Inc | Buy | 5,50055,269 held (+11%) | $3.55 | $20K | +11.0% |
| Dec 23SEC | GALTGalectin Therapeutics Inc | Buy | 5,50055,269 held (+11%) | $3.55 | $20K | +11.0% |
- Buy
Director Kevin D Freeman bought $20K of GALT at $3.55 — first open-market purchase in our records.